Drug targets for COVID-19 therapeutics: Ongoing global efforts
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12038-020-00067-w.pdf
Reference290 articles.
1. 2020 Coronavirus: Everyone wins when patents are pooled. Nature 581 240
2. Abbas AR, Abbas A, Ali Y and Memon SF 2020 Important considerations regarding the future management of coronavirus (COVID-19). Int. J. Surg. 79 6–7
3. Abbasi J 2016 Repurposing drugs to treat Zika. JAMA 316 1636
4. Agostini ML, Pruijssers AJ, Chappell JD, Gribble J, Lu X et al. 2019 Small-molecule antiviral beta-d-N (4)-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance. J. Virol. 93 https://doi.org/10.1128/JVI.01348-19
5. Aguilera E, Alvarez G, Cerecetto H and Gonzalez M 2019 Polypharmacology in the treatment of chagas disease. Curr. Med. Chem. 26 4476–4489
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Severe acute respiratory syndrome Coronavirus-2 GenoAnalyzer and mutagenic anomaly detector using FCMFI and NSCE;International Journal of Biological Macromolecules;2024-02
2. Inhibitory Activity of Flavonoid Scaffolds on SARS-CoV-2 3CLpro: Insights from the Computational and Experimental Investigations;Journal of Chemical Information and Modeling;2024-01-26
3. Thermodynamic and Kinetic Characteristics of Molnupiravir Tautomers and Its Complexes with RNA Purine Bases as an Explanation of the Possible Mechanism of Action of This Novel Antiviral Medicine: A Quantum-Chemical Study;The Journal of Organic Chemistry;2023-09-27
4. Searching possible SARS-CoV-2 main protease inhibitors in constituents from herbal medicines usingin silicostudies;Journal of Biomolecular Structure and Dynamics;2023-06-22
5. Clinically Evaluated COVID-19 Drugs with Therapeutic Potential for Biological Warfare Agents;Microorganisms;2023-06-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3